98 related articles for article (PubMed ID: 16118701)
1. Cannabinoids.
Lawson K
IDrugs; 1999 Oct; 2(10):977-9. PubMed ID: 16118701
[TBL] [Abstract][Full Text] [Related]
2. British Pharmacological Society--summer meeting.
Chazot P
IDrugs; 1999 Oct; 2(10):974-6. PubMed ID: 16118700
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects.
Izzo AA; Camilleri M
Gut; 2008 Aug; 57(8):1140-55. PubMed ID: 18397936
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptors: where they are and what they do.
Mackie K
J Neuroendocrinol; 2008 May; 20 Suppl 1():10-4. PubMed ID: 18426493
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?
Oesch S; Gertsch J
J Pharm Pharmacol; 2009 Jul; 61(7):839-53. PubMed ID: 19589225
[TBL] [Abstract][Full Text] [Related]
6. Natural cannabinoids: templates for drug discovery.
Thakur GA; Duclos RI; Makriyannis A
Life Sci; 2005 Dec; 78(5):454-66. PubMed ID: 16242157
[TBL] [Abstract][Full Text] [Related]
7. British Pharmacological Society Cambridge Symposia. 5-7 January 2000, Cambridge, UK.
Lawson K
IDrugs; 2000 Apr; 3(4):373-6. PubMed ID: 16100689
[TBL] [Abstract][Full Text] [Related]
8. The British Pharmacological Society--winter meeting. Neuropharmacology. 6-8 January 1999, Brighton, UK.
Chazot P
IDrugs; 1999 Mar; 2(3):214-6. PubMed ID: 16160928
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2.
McHugh D; Tanner C; Mechoulam R; Pertwee RG; Ross RA
Mol Pharmacol; 2008 Feb; 73(2):441-50. PubMed ID: 17965195
[TBL] [Abstract][Full Text] [Related]
10. Endogenous cannabinoids and neutrophil chemotaxis.
McHugh D; Ross RA
Vitam Horm; 2009; 81():337-65. PubMed ID: 19647118
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids.
Hanus LO
Med Res Rev; 2009 Mar; 29(2):213-71. PubMed ID: 18777572
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid system and neuroinflammation: implications for multiple sclerosis.
Correa F; Docagne F; Mestre L; Loría F; Hernangómez M; Borrell J; Guaza C
Neuroimmunomodulation; 2007; 14(3-4):182-7. PubMed ID: 18073512
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid signalling in the enteric nervous system.
Galligan JJ
Neurogastroenterol Motil; 2009 Sep; 21(9):899-902. PubMed ID: 19689654
[TBL] [Abstract][Full Text] [Related]
14. Basic neuroanatomy and neuropharmacology of cannabinoids.
Breivogel CS; Sim-Selley LJ
Int Rev Psychiatry; 2009 Apr; 21(2):113-21. PubMed ID: 19367505
[TBL] [Abstract][Full Text] [Related]
15. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
McCarberg BH; Barkin RL
Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
[TBL] [Abstract][Full Text] [Related]
16. British Pharmacological Society Cambridge Symposia. Pharmacology for the next millennium. 5-7 January 2000, Cambridge, UK.
Chazot P
IDrugs; 2000 Apr; 3(4):377-8. PubMed ID: 16100690
[TBL] [Abstract][Full Text] [Related]
17. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
[TBL] [Abstract][Full Text] [Related]
18. Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids.
Oz M
Pharmacol Ther; 2006 Jul; 111(1):114-44. PubMed ID: 16584786
[TBL] [Abstract][Full Text] [Related]
19. [The modulatory role of endocannabinoids in sleep].
Murillo-Rodríguez E
Rev Neurol; 2008 Feb 1-15; 46(3):160-6. PubMed ID: 18297624
[TBL] [Abstract][Full Text] [Related]
20. [The mechanism of action of cannabis and cannabinoids].
Scholten WK
Ned Tijdschr Geneeskd; 2006 Jan; 150(3):128-31. PubMed ID: 16463612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
